Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma

This publication has 22 references indexed in Scilit:

• Pulmonary toxicity of ABVD chemotherapy and G-CSF in Hodgkin's disease: possible synergy
  The Lancet, 1993
• Cytotoxic drug-induced pneumonia and possible augmentation by G-CSF — clinical attention
  Annals of Hematology, 1993
• Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1992
• Neutrophil priming by granulocyte colony stimulating factor and its modulation by protein kinase inhibitors
  Biochemical Pharmacology, 1992
• GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATION
  The Lancet, 1989
• Pharmacology of the colony-stimulating factors
  Trends in Pharmacological Sciences, 1989
• Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.
  Journal of Clinical Investigation, 1988
• Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium
  New England Journal of Medicine, 1988
• EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPY
  The Lancet, 1988
• Pulmonary complications associated with combination chemotherapy programs containing bleomycin
  The American Journal of Medicine, 1983